Simoctocog alfa

N/A

Report date: 2026/03/31 20:00:21

Base Information

Drug NameSimoctocog alfa
Drug Alias Nameシモクトコグアルファ (遺伝子組換え)Simoctocogum alfa (Octapharma)重组辛凝血素-8α重组塞莫凝血素αSimoctocog alpha/Antihemophilic Factor (Octapharma) +[12] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsHemophilia A
Approved Indications in ChinaHemophilia A
Original Approved Country/TerritoryEU
Original Approved Date2014/07/22
Country/TerritoryBulgariaCanadaUnited States +[29] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOctapharma
China Registration ClassN/A

Develop Information

Active CompaniesFujimoto PharmaceuticalOctapharma Ab
Inactive CompaniesOctapharmaOctapharma Gmbh Dessau
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeB02BD02
Related LinksDrugBankKEGG